The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues
- PMID: 10202129
- DOI: 10.1006/scbi.1998.0119
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues
Abstract
The human CEA family has been fully characterized. It comprises 29 genes of which 18 are expressed; 7 belonging to the CEA subgroup and 11 to the pregnancy specific glycoprotein subgroup. CEA is an important tumor marker for colorectal and some other carcinomas. The CEA subgroup members are cell membrane associated and show a complex expression pattern in normal and cancerous tissues with notably CEA showing a selective epithelial expression. Several CEA subgroup members possess cell adhesion properties and the primordial member, biliary glycoprotein, seems to function in signal transduction or regulation of signal transduction possibly in association with other CEA sub-family members. A modified ITAM/ITIM motif is identified in the cytoplasmatic domain of BGP. A role of CEA in innate immunity is envisioned.
Copyright 1999 Academic Press.
Similar articles
-
[The carcinoembryonic antigen: apropos of an old friend].Rev Invest Clin. 2005 Nov-Dec;57(6):814-9. Rev Invest Clin. 2005. PMID: 16708907 Review. Spanish.
-
Carcinoembryonic antigen: cell adhesion molecule and useful diagnostic marker.Br J Biomed Sci. 1999;56(3):209-14. Br J Biomed Sci. 1999. PMID: 10824332 Review.
-
Down-regulation of carcinoembryonic antigen family member 2 expression is an early event in colorectal tumorigenesis.Cancer Res. 1997 May 1;57(9):1776-84. Cancer Res. 1997. PMID: 9135022
-
Radical differences in functions of closely related members of the human carcinoembryonic antigen gene family.Cell Growth Differ. 1996 May;7(5):655-62. Cell Growth Differ. 1996. PMID: 8732675
-
Biosynthesis of carcinoembryonic antigen (CEA) gene family members expressed in human tumor cell lines: evidence for cleavage of the glycosyl phosphatidyl inositol (GPI) anchor by GPI-PLC and GPI-PLD.Biochem Int. 1991 Nov;25(4):723-31. Biochem Int. 1991. PMID: 1815506
Cited by
-
Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis.Mol Biomed. 2024 May 24;5(1):19. doi: 10.1186/s43556-024-00181-3. Mol Biomed. 2024. PMID: 38782774 Free PMC article.
-
Tumor biomarkers for diagnosis, prognosis and targeted therapy.Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2. Signal Transduct Target Ther. 2024. PMID: 38763973 Free PMC article. Review.
-
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials.Nat Commun. 2024 May 15;15(1):4091. doi: 10.1038/s41467-024-48479-8. Nat Commun. 2024. PMID: 38750034 Free PMC article. Clinical Trial.
-
Genetically engineered bacteriophages as novel nanomaterials: applications beyond antimicrobial agents.Front Bioeng Biotechnol. 2024 Apr 25;12:1319830. doi: 10.3389/fbioe.2024.1319830. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38725991 Free PMC article. Review.
-
Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody.Front Immunol. 2024 Apr 24;15:1378813. doi: 10.3389/fimmu.2024.1378813. eCollection 2024. Front Immunol. 2024. PMID: 38720892 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous